Full Report

Claude View

Know the Business

Oil-Dri is a vertically integrated clay miner that turns a free-from-the-ground commodity (calcium bentonite, attapulgite, diatomaceous shale) into two very different businesses: a low-margin retail cat-litter franchise that fights Clorox and Church & Dwight on supermarket shelves, and a much higher-margin B2B fluids-purification business that sells bleaching clays and adsorbents to renewable-diesel and edible-oil refiners. The market still prices ODC like a sleepy small-cap consumer-products company; the real story over the last three years is the B2B segment, where renewable-diesel demand has driven segment operating margin to ~33% and pulled consolidated ROIC to 36%. The biggest things to underestimate or overestimate: how fundamentally B2B (not litter) now drives incremental profit, and how thin the consumer-litter moat actually is.

How This Business Actually Works

ODC mines its own clay on owned/leased land near five U.S. plants, dries it in natural-gas-fired kilns, and then either bags it (cat litter, floor absorbents) or further activates it (bleaching clays, adsorbents). The economics are dominated by three line items: clay (essentially free, but capex-heavy to mine and dry), natural gas (kiln fuel — the swing variable for gross margin), and freight (clay is heavy, low-value-per-ton, and ships poorly).

Two segments produce wildly different unit economics from the same clay. Retail & Wholesale is 62% of revenue but only 42% of segment operating income; B2B is 38% of revenue but 58% of segment OI, with ~33% segment operating margin versus ~15% in Retail. The reason is bargaining power: Walmart (19% of total sales) buys cat litter on price, while a renewable-diesel refiner buying Metal-X adsorbent buys on performance — a $5/ton price cut on the clay does not move the needle versus a fuel-yield improvement.

The bottleneck is kilns (gas + capex), not clay. ODC has 207.6M tons of proven and probable reserves — roughly 40+ years of supply. Reserves are not the moat; the moat (such as it is) is the combination of plant location near reserves, technical formulation IP in B2B, and long-running co-pack relationships — notably the exclusive Fresh Step coarse-litter supply agreement with Clorox, which is simultaneously a major customer and a direct shelf competitor.

The Playing Field

ODC is a sub-$1B oddity in a peer set dominated by $20B+ branded consumer giants and mid-cap specialty miners. The right way to read this table is: ODC's headline returns rival or exceed every peer, but on a tiny absolute base.

ODC sits in a unique corner: its operating margin is below CHD/CLX (the branded consumer giants have pricing power on shelf), but its ROIC is the best in the entire set — a function of how little tangible capital the business needs once mines and kilns are paid for. The specialty mineral peers (MTX, CMP, SCL) are loss-making or barely positive on operating margin and trade at distressed multiples. ODC is not a CHD-lite consumer compounder, and it is not a CMP/MTX-style commodity miner — it is a hybrid, and the B2B mix is what makes the math work.

Is This Business Cyclical?

Yes — and the cycle hits at the cost line, not the revenue line. ODC's revenue has grown every year for five years; its earnings have not. The single most important cycle to understand is the natural-gas/freight inflation of FY2022, when consolidated net income collapsed 49% on a +14% revenue year because kiln gas costs jumped 108% YoY and freight per ton rose 27%. Pricing actions then rebuilt margin over the next 24 months.

Three distinct cycles run through this business at different speeds:

1. Input-cost cycle (12–18 months). Natural gas, freight, packaging resin. ODC has limited hedging — it forward-contracts a portion of kiln fuel — so margins compress before pricing catches up. This is the FY2022 story.
2. Renewable-diesel demand cycle (multi-year). B2B fluids purification grew 19% in FY25 driven by Metal-X/Metal-Z adsorbents going into renewable-diesel pretreatment. This is the upcycle ODC is currently riding. Watch for changes in U.S. blender's tax credits or biomass-based diesel RIN economics — if RD margins compress, refiner volumes could fall.
3. Pet-spending cycle (mild). Cat-litter volume is more recession-resilient than discretionary pet spend, but private-label trade-down is a margin headwind in downturns. The Ultra Pet (crystal litter) acquisition in May 2024 added premium-priced revenue but exposes the company to a faster-moving consumer category.

The Metrics That Actually Matter

Don't fixate on revenue or EPS growth in isolation — both are noisy. The four metrics below are what separate value creation from financial-engineering noise in this business.

The reason ROIC matters more than ROE here: ODC has very little debt (D/E 0.15), so ROE and ROIC barely diverge. A 36% ROIC on a vertically integrated mining + manufacturing business is genuinely unusual — it tells you the kilns and mines are largely depreciated and incremental tons drop a lot to the bottom line. The number to watch is whether new capex (FY2025 capex of $32.5M was up sharply for B2B capacity expansion) starts to drag ROIC back toward peer levels.

The metric most analysts get wrong: P/E. With Class A and Class B share structures, a 2-for-1 stock split in January 2025, and the Ultra Pet acquisition mid-FY24, trailing per-share numbers are messy. Use EV/EBITDA (~9x) and segment-level operating income trends instead.

What I'd Tell a Young Analyst

Three things to pin to the wall:

1. The B2B segment is the entire investment case right now. The bulk of FY2025's revenue and operating-income growth came from fluids purification (renewable diesel) and agricultural carriers — B2B segment operating income grew 31% on 21% revenue growth, while Retail OI was flat year-over-year. If you can't get conviction on whether U.S. renewable-diesel demand keeps growing, you can't get conviction on ODC. Retail cat litter is the boring, defensive base; B2B is the option.

2. The moat is narrower than the financials suggest. A 36% ROIC says "wide moat" but most of it comes from depreciated plant and free-from-the-ground clay — replacement-cost economics are far worse than reported. In retail, ODC competes against Clorox (Fresh Step) and Church & Dwight (Arm & Hammer) without their brand or marketing budgets, and one of its biggest customers (Clorox, via the Fresh Step co-pack agreement) is also its biggest direct competitor in the same aisle. If Clorox ever insourced coarse-litter manufacturing, that's a real revenue hole.

3. Watch input costs the way you'd watch refining margins. Natural gas per ton and domestic freight per ton are the swing variables. ODC explicitly discloses both in MD&A. When these inflect up faster than ODC can re-price (FY22 was the textbook example), gross margin compresses 300+ bps in a single year. When they normalize and pricing sticks (FY23–FY25), gross margin re-expands and earnings explode. This is a margin story dressed up as a revenue story.

What would change the thesis: a sustained drop in renewable-diesel feedstock pretreatment volumes; loss of the Walmart account or Clorox co-pack contract; a value-destroying acquisition (Ultra Pet was ~$50M — meaningfully larger deals would matter); or a return of FY22-style input-cost inflation without commensurate pricing power.

Claude View

The Numbers

ODC trades at roughly 20x trailing earnings and 14.5x EV/EBITDA on a ~$1.3B market cap, which sounds like a premium for a small-cap clay miner — until you look at the returns the business is actually generating. FY2025 delivered 29.5% gross margin, 14.1% operating margin, 20.8% ROE and a 36.5% ROIC, the highest profitability in company history, on an 11% revenue gain to $485.6M. The single metric most likely to rerate or derate this stock from here is gross margin: every 100 bps of durable margin expansion drops straight through a lean cost structure, and the market has been paying up for each incremental point since the Ultra Pet acquisition closed.

Valuation Snapshot

Net cash position (~$10.6M), 2.56x current ratio, 28x interest coverage and 0.15x debt/equity — the balance sheet is one of the cleanest in the small-cap chemicals universe. ODC is not trading at this multiple because of leverage risk. It is trading here because the market has (correctly) identified the last three years as a structural margin upgrade, not a cyclical pop.

Price: A One-Year Double

The stock is up ~70% over twelve months, punched through the prior all-time high in late FY2025 around $67, pulled back 30% from October to early January as the market digested the Q1-FY2026 margin pause, then rallied another 45% on the Q2-FY2026 print and buyback news. Today's $73.47 is within 1% of the 52-week high, and the 60-day average ($64.40) sits meaningfully above the 200-day ($59.59) — a clean "higher highs, higher lows" setup heading into Q3-FY2026.

Revenue & Earnings Power

Margin Ladder — The Rerating Engine

This is the single most important chart on the page. Gross margin has climbed 700 bps in four years and operating margin has tripled. The rerating from ~8x EV/EBITDA to 14.5x tracks this ladder almost one-for-one. Any sign of a reversal — even flat margin for two quarters — would likely compress the multiple back toward the historical 9–10x range.

Cash Generation & Capital Allocation

Operating cash flow jumped 33% in FY2025 to a record $80.2M. CapEx held flat at $32.6M (6.7% of sales — high for chemicals but typical for a miner running its own pits and plants), so free cash flow nearly doubled to $47.6M. On a trailing-twelve-month basis through Q2-FY2026, FCF is tracking $62.6M — a 4.7% yield on today's market cap.

The capital-return picture shifted decisively in FY2026. Through the first half alone, ODC bought back $19.3M of stock — more than the previous four years combined — while the dividend grew to $0.205/share quarterly (~$0.82 annualized, ~1.1% yield). Acquisitions (Ultra Pet, $44M in FY2024) drove the revenue step-up but are not currently in the pipeline; management appears to be using the higher multiple to return cash rather than hunt for deals.

Per-Share Economics & Dilution

Note: ODC executed a 2-for-1 stock split in early FY2025; FY2024 EPS is shown split-adjusted here for comparability. The as-reported FY2024 diluted EPS was $5.43 on ~8.8M shares. Share count rose from ~8.8M pre-split to ~17.9M post-split. Book value per share has grown at a double-digit pace even after split and dividend leakage, reflecting retained earnings compounding at 20%+ ROE.

Balance Sheet — The Fortress

FY2024 leverage ticked up to fund Ultra Pet; by FY2025, cash ($50.5M) exceeded total debt ($39.8M) — ODC ended the year in a net-cash position for the first time in three years. Debt/equity fell from 0.24x to 0.15x. Interest coverage at 28x means debt service is a rounding error.

Peer Comparison — Why ODC Trades Here

ODC occupies a specific seat at this table: small-cap with big-cap returns. On ROIC (36.5%) it beats every single peer including CHD (13.0%) and CLX (25.9%). On operating margin (14.1%) it sits inside the CPG cluster. On multiples, it trades at a discount to CHD (the closest strategic comp at 32x P/E and 19x EBITDA) but a premium to the commodity-minerals peers (MTX, CMP, SCL). That premium to minerals peers is the valuation risk — if the market ever decides ODC is "just a clay miner," it derates toward 8–10x EBITDA. The bull case is that the Ultra Pet-augmented retail mix and sustained margin performance earn a durable CPG multiple.

ROIC vs Valuation — The Quality Premium

The scatter makes the case visually: ODC is the only peer sitting in the high-ROIC / mid-multiple quadrant. CHD earns a higher multiple but with less than half the ROIC. CLX earns comparable ROIC at a lower multiple but with a negative-book capital structure. The minerals peers (MTX, CMP, SCL) earn low-single-digit ROIC and don't deserve premium multiples.

Seasonality & Latest Quarterly Read

The most recent quarter (Q2-FY2026, Jan 2026) showed a slight margin slip: gross margin 27.4% vs 29.5% prior quarter and 29.5% prior-year Q2. Operating margin held at 13.3%. Revenue $117.7M and diluted EPS $0.87 came in essentially flat vs the year-ago quarter. This is the crack that explains the October-to-January drawdown. Q3-FY2026 (reports June 2026) is the next catalyst — stabilization or recovery validates the multiple; a second consecutive 100+ bps compression would likely trigger a rerate lower.

Shareholder Base

The institutional book is concentrated: BlackRock 733K shares, Dimensional 518K, American Century 419K, Diamond Hill 141K, Bard 102K, Bank of NY Mellon 98K, Cardinal 88K, Schwab 87K. Combined with founder-family (Jaffee) control of a sizable voting block, the effective float is thin, which explains the jagged intraday moves on quarterly prints. Options are effectively non-existent — Alpha Vantage returned no listed options chain — so all volatility is spot-driven and hedging has to be done with the stock itself.

What the Numbers Confirm, Contradict, and What to Watch

The numbers confirm the thesis: ODC has engineered a structural margin upgrade (gross margin from 25% to 29.5%), generates FCF at a 4.7% trailing yield, carries a net-cash balance sheet, earns 36.5% ROIC, and is returning capital aggressively (H1 FY2026 buybacks already exceed the prior four years combined). The numbers contradict any "cheap value" framing — at 20x earnings and 14.5x EBITDA, ODC is now priced as a quality compounder, not a forgotten small-cap. Watch Q3-FY2026 gross margin (reports June 2026): a flat-to-up print validates the rerating; two consecutive quarters of compression below 28% would be the derating trigger, because the entire premium to minerals peers rests on margin durability.

Claude View

People & Governance

Oil-Dri earns a B-minus. This is a third-generation, founder-controlled company whose CEO-chairman owns voting control outright, has never sold a share on the open market, and has quietly compounded the dividend for 22 consecutive years — but the same family grip produces a thin independent check on pay, two nepotism-style employment relationships, a large recurring legal-fee payment to a director's law firm, and a pledged 260,000-share personal loan collateral. The economics work because the controller behaves like an owner, not an operator; the governance structure is only as good as that owner's next decision.

The People Running This Company

The management bench is small, long-tenured, and dominated by one figure. Daniel S. Jaffee has been CEO for 28 years and Chairman for 7 — he joined the company in 1987, became CFO in 1990, COO in 1995, CEO in 1997, and Chairman in 2018, giving him a level of institutional memory that is genuinely rare in US small-cap industrials. Susan Kreh is the seasoned operator underneath him; she came from Johnson Controls' Power Solutions division where she ran finance and IT for a multi-billion dollar business, and has been CFO/CIO since 2018. Christopher Lamson (ex-Central Garden & Pet, ex-Kimberly-Clark) and Aaron Christiansen (26-year internal manufacturing veteran) round out the operating team. Tenure is long, and there is no evidence of dysfunction — but succession is the elephant in the room: the 2025 proxy and 10-K contain no named successor, no internal-outside horse race, and no age-driven handoff plan despite Jaffee being 61.

Jaffee's reputation profile is unusually positive for a small-cap controller: he guest-lectures on ethical leadership at Kellogg and Marquette, serves on Chicago civic boards, and inherited the job from a father (Richard M. Jaffee) and grandfather (founder Nick Jaffee) who ran the business before him. The one biographical red flag is the concentration of authority — under the proxy's own description, the Annual Incentive Plan gives Mr. Jaffee personal "discretion to adjust the performance measures, targets and payout ranges" and to increase or decrease any participant's cash incentive by up to 25%, subject to limits. That is real, unilateral compensation power over everyone below him.

What They Get Paid

Executive pay at ODC is reasonable in absolute terms for a $826M market-cap industrial and disciplined relative to performance. Jaffee's fiscal 2025 total comp was $2.30M — down from $3.30M in FY2023 — and the big FY2024 number of $10.60M reflected a one-time 250,000-share restricted Class B stock grant that vests through October 2028 and explicitly substitutes for Executive Deferred Bonus awards he voluntarily chose not to take. Stripping that multi-year grant out, his run-rate base-plus-cash-incentive sits under $2.5M, which translates to a CEO-to-median-employee pay ratio of 29:1 — far below the S&P 500 average (roughly 250:1) and reasonable for a business this size. Kreh, Lamson, Christiansen and Scheland each received outsized $1.0M-$1.3M stock grants in FY2025 as a retention device; those cliff-vest in 2029-2030.

Pay is tied to adjusted pre-tax, pre-bonus income. FY2025 came in at $79.2M, which was above target and triggered 139.4% of target bonuses. This is a reasonable single-metric design for a mature industrial, though sophisticated plans typically use multiple measures (growth, margin, ROIC, relative TSR). There is no severance plan, no employment agreement, and no change-in-control gross-up for any executive — a genuinely shareholder-friendly practice. The Compensation Committee benchmarks against a peer group only "from time to time" and chose not to benchmark for fiscal 2025, on the stated rationale that over-reliance on benchmarking ratchets pay upward. That is an unusually restrained stance, and it shows in the numbers.

Are They Aligned?

Ownership and Control

The Jaffee family votes 69.7% of aggregate power through a dual-class structure that is not going away. Class B stock carries 10 votes per share; Common carries 1. Daniel personally owns 1.198M Class B shares (28.06% of Class B) and the Jaffee Investment Partnership — a Delaware LP whose four general partners are Daniel and his three siblings, with Daniel controlling 11 of 20 partner votes — holds another 2.500M shares (58.55% of Class B). He owns no Common stock directly. Institutional ownership of Common is meaningful (GAMCO 9.39%, BlackRock 7.01%, Dimensional 5.43%, Vanguard 5.29%, Needham 5.01%) but institutions vote only a minority share of aggregate power because Common is one-vote-per-share.

The gap between the two bars is the governance story. The Jaffee block votes 69.7% on roughly 25.3% economic interest — a voting premium of about 2.75x. That is the price outside investors pay for a stable, family-run compounder, and it is substantial.

Insider Buying and Selling

Over the trailing twelve months, insiders have executed zero open-market purchases and eight open-market sales totalling $1.23M across six people — Hindsley ($383k), Chube ($288k), Robey ($238k), Lamson ($154k), Scheland ($103k split across two days) and Ryan ($61k). These are small trims against much larger holdings and none look distress-motivated. Most importantly, Daniel Jaffee has never sold a share on the open market over the four years of available Form 4 data; his "dispositions" are limited to statutory tax withholdings on restricted-stock vesting and one small gift to charity. That is the single strongest alignment signal in this file.

Dilution and Equity Grants

Equity grants in FY2025 were concentrated in four NEOs (Kreh, Lamson, Christiansen, Scheland) with 25,000-share one-time retention grants valued at roughly $1.04M each. Jaffee himself did not receive a new stock award in FY2025 — his FY2024 grant of 250,000 restricted Class B shares was sized to cover four years of deferred bonuses in one action, and the remaining unvested portion (268,000 shares) vests through October 2028. Total share count sits at 10.37M Common plus 4.27M Class B (14.64M) — a disciplined equity program, not a dilution factory. Separately, the company repurchased over 150,000 shares year-to-date in fiscal 2026 while continuing to raise the dividend.

Capital Allocation Behavior

This is where the owner-operator model delivers value. Oil-Dri has paid a continuous quarterly cash dividend since 1974 and has raised it annually for 22 consecutive years, most recently a 16% hike announced June 2025 (to $0.18/quarter on Common, $0.135 on Class B). The company simultaneously runs an opportunistic buyback program and invests capex for capacity and mineral reserves. That is exactly the capital-allocation pattern a long-horizon family owner should produce — no empire-building M&A, no aggressive leverage, a debt-to-equity of 0.15x, and a current ratio of 2.56x. The recent Ultra Pet acquisition (crystal / silica cat litter) was a tuck-in sized to operating cash flow, not a bet-the-company move.

Related-Party Behavior — The Real Concerns

Three recurring related-party items deserve attention, though none is individually disqualifying.

The Roeth / Central Garden & Pet link is not material — only $413,176 in total net sales in FY2025, and the commercial relationship pre-dates Roeth joining either board.

Skin-in-the-Game Score

7 / 10. The CEO controls roughly 3.7M shares between direct holdings and family-partnership holdings (about $272M at the current $73.47 price) and has never sold on the open market in the data window. Pay is modest relative to market cap, the CEO-to-median ratio is 29:1, and the company compounds dividends rather than options grants. Points are deducted for the pledged loan collateral, the two family employees, the recurring director-firm legal bill, the non-independent Compensation Committee member, and the absence of a disclosed succession plan.

Board Quality

The nine-person board looks reasonable on paper: seven of nine directors are formally independent under NYSE standards, and the Audit Committee is fully independent with two designated financial experts (Washow and Hindsley). But three features of the actual structure matter more than the independence ratio.

First, the Compensation Committee is not fully independent — Nemeroff, whose law firm receives $1.6M per year from ODC, sits on the committee that sets Jaffee's pay. Two of three members (Chube and Selig) are independent and are the designated deciders for Section 16 equity matters, but the committee has no written charter and operates under the controlled-company exemption. Second, the Nominating Committee is newly created (2021) and also has no written charter — which means the Board's own refreshment process is under-specified despite recent additions of Ryan (2021) and Schmeda (2023). Third, tenure is skewed: Selig has served since 1969 (56 years, now age 91) and Nemeroff since 2006; these are the two Compensation Committee members most directly tied to Jaffee's professional and personal circle. The independent Lead Director role (held by Roeth, an ex-Clorox / Central Garden & Pet CEO) partially compensates, and the Board confirms that non-management directors meet in executive session at every regular meeting.

Director expertise is fit-for-purpose: Washow ran AMCOL (the bentonite-clay peer now owned by Minerals Technologies), Roeth ran both Clorox's consumer household division and Central Garden & Pet, Hindsley is a William Blair M&A banker, Ryan brings EHS / sustainability given Oil-Dri's mining footprint, and Schmeda brings IT and cybersecurity. Missing: no sitting public-company CFO, no international operations specialist despite Amlan's international footprint, and no technology / data specialist beyond the CIO level. Director attendance was 100% in fiscal 2025 — but the Board held only four meetings, which is on the low side for a public issuer.

The Verdict

Grade: B-minus. The case for this company begins and ends with the owner. Oil-Dri is run by a third-generation family owner who has been at the business for 38 years, owns roughly $272M of his own stock, has never sold a share on the open market, has raised the dividend for 22 consecutive years, avoids empire-building M&A, refuses lavish executive pay benchmarking, and reinvests in mining reserves and capacity. That is an unusually clean capital-allocation track record for a US small cap, and it deserves real credit.

The case against is entirely structural, not behavioral: a dual-class setup permanently enshrines family voting control at roughly 2.75x their economic stake; the Compensation Committee includes a director whose firm bills $1.6M a year; two members of the extended Jaffee family hold part-time executive roles drawing combined compensation near $700k; the CEO has pledged $14.7M of Class B stock as personal loan collateral; there is no disclosed succession plan despite the CEO's 28-year tenure; and the Board operates multiple committees without written charters under the controlled-company exemption. None of these individually is a disqualifier — but together they mean minority shareholders are essentially betting on the Jaffee family's continued good judgment, with no effective independent check.

Claude View

The Full Story: 1941 Clay, 2026 Compounder

For eighty-five years the story of Oil-Dri Corporation of America has been the story of a Chicago family, a bulldozer, and a hole in the ground. Nick Jaffee started the business in 1941 selling clay granules to garages to soak up oil on factory floors; his grandson Daniel now runs an $826 million-market-cap public company that mines 207 million tons of proven bentonite reserves and sells the crushed, kiln-dried output into cat litter, renewable-diesel filters, chicken feed, and baseball infields. The arc from absorbent to adsorbent — from mopping up liquids to selectively pulling impurities out of them — is the single most important shift in how management talks about the business, and it is the reason a sleepy family-controlled micro-cap compounded 228% since August 2022 while consumer-staples giants stagnated. What changed is the mix. What did not change is the Jaffee family's grip on capital allocation, the willingness to let margin evaporate during input-cost shocks, and the institutional patience to wait out a goodwill impairment and come back stronger. Management credibility today is the highest it has been in a decade.

1. The Narrative Arc

Five fiscal years condense into five acts. FY2021 was the COVID pet-adoption boom that never quite turned into margin — revenue hit a then-record $305M but net income fell 41% as commodity and freight costs ate everything. FY2022 was the crisis: natural-gas costs per ton jumped 108%, the Retail & Wholesale segment took a $5.6M goodwill impairment, net income collapsed to $5.7M ($0.81 EPS), and the stock got re-rated as a broken commodity play. FY2023 was the mechanical recovery — pricing actions finally stuck, gross margin rebounded from 18% to 25%, and net income rocketed to $29.6M (+421%). FY2024 was the pivot: the $46M Ultra Pet acquisition closed May 1, 2024, bringing silica-gel crystal litter and Netherlands distribution; fluids-purification volume surged on renewable-diesel demand; diluted EPS cleared $5.43 on the old share count. FY2025 was validation — record $485.6M revenue, $54.0M net income, a 2-for-1 stock split, and the lightweight-litter flywheel hitting seven consecutive quarters of growth for the EPA-approved Cat's Pride Antibacterial Clumping product launched in FY2023.

2. What Management Emphasized — and Then Stopped Emphasizing

Across five 10-Ks and six quarters of earnings releases, the vocabulary has rotated cleanly. COVID-19, supply chain, pandemic, and backlog dominated FY2021–FY2022. By FY2024 those words were vestigial. In their place: renewable diesel, Ultra Pet, crystal litter, antibacterial, and Amlan. The company is still selling the same clay, but the story wrapped around it has moved from "resilient through disruption" to "diversified high-value sorbents."

Two themes quietly disappeared. The first is Amlan as a growth engine. For three years (FY2021–FY2023) management "invested" in the animal-health business with higher headcount and marketing. The narrative promised operating leverage that never fully arrived, and by Q2 FY2026 Amlan's sales had dropped 32% after losing a distributor's key customer — a rare on-the-record admission that a "growth pillar" had become an execution problem. The second is the UK subsidiary, which quietly got reclassified from Retail into B2B in FY2022 and has been shrinking ever since. Neither is disastrous. Both are telling, because management has stopped trying to sell them as upside.

The themes that grew in volume — renewable-diesel filtration, crystal-cat-litter, antibacterial litter — are all higher-margin, higher-technology, and less commoditized than the old clay-pellet core. That is the real strategic transformation hiding behind eighty-five years of continuity.

3. Risk Evolution

The 10-K risk factor sections tell you what management is worried about at 3am. Over five years the worry list rotated from macro-driven, uncontrollable fears (pandemic, inflation, gas prices) to strategic-execution risks (integrating Ultra Pet, defending retail shelf space, customer concentration at Walmart).

Three shifts stand out. Climate risk rose steadily — not coincidentally, Winter Storm Fern hit three Oil-Dri plants in Q2 FY2026 and cost the company revenue it cannot recover until Q3. Acquisition-integration risk appeared from zero in FY2024, peaked, and is now easing as Ultra Pet beds in. Walmart concentration risk (19–20% of sales) has crept up in emphasis, which matters because the same retailer that made the business is also its single largest point of fragility.

What management removed: the pension-plan risk (terminated in FY2023, one-time $4.7M charge taken and done) and most pandemic language. Both deletions are credible — the actions backed the words.

4. How They Handled Bad News

Oil-Dri's handling of setbacks is the tell on whether this is a well-governed small-cap or a family-controlled black box. On the three largest pieces of bad news in the past five years, management was blunt in print.

The FY2022 goodwill impairment ($5.6M write-down of Retail & Wholesale goodwill) was disclosed with unusual candor: management attributed it to "lower share prices and the continued adverse impacts of rising costs," which is a rare public acknowledgment that the stock price itself was a triggering event. No euphemisms.

The FY2023 pension termination cost $4.7M in one quarter, was flagged in advance, and was bundled with a $2.5M Georgia landfill-capacity reserve. Both were taken cleanly, not smuggled into adjusted EBITDA.

The Q2 FY2026 Winter Storm Fern disruption — the most recent setback — is the template: Daniel Jaffee led the March 2026 release by naming the storm, quantifying the revenue slippage into Q3, and pairing it with the counterweight:

"At this point in time, we are tracking to our annual plan. To the extent we are able continue this trend, we anticipate that we will surpass last year's annual net income."

That sentence matters. It is a soft reaffirmation of the FY2026 plan inside a press release describing a 3% year-over-year net income decline. It is also falsifiable — by the time the FY2026 10-K is filed, we will know whether they hit it. That is the discipline of a management team that has stopped needing to manage the narrative.

What is missing from every bad-news disclosure is any attempt to shift blame outside management's control beyond the specific event. There is no "macro headwind" hand-waving. That discipline is rarer than it should be in specialty-chemicals.

5. Guidance Track Record

Oil-Dri does not issue quantitative annual guidance — a deliberate choice consistent with its family-controlled, long-horizon posture. What management does commit to is a smaller set of directional and strategic promises. Those are tractable.

Credibility = 8.5 / 10. This is management that under-promises, executes operationally, and tells you when a business unit is struggling (Amlan) instead of dressing it up. The single material miss is the Amlan animal-health franchise that was sold as a growth pillar for four years and is now contracting. The rest of the scorecard — renewable diesel, crystal litter, margin rebuild, Ultra Pet integration, and the symbolic 2-for-1 split — was delivered on or ahead of schedule. Daniel Jaffee has been CEO since August 1997 and Chairman since 2018; he is not going to torch 28 years of narrative discipline in Year 29.

6. What the Story Is Now

The current Oil-Dri story is simpler than it was in FY2022 and more durable than it was in FY2021. Strip away the weather noise and the business is a two-segment specialty-minerals franchise where 63% of FY2025 revenue comes from Retail & Wholesale (cat litter, industrial, sports) and 37% from Business-to-Business (fluids purification, agricultural carriers, animal health). The B2B segment is the story engine — it grew 21% in FY2025 on renewable-diesel and agricultural momentum, and carries 33% segment operating margins versus 15% in Retail. The Retail segment is the earnings stabilizer, anchored by a decades-old Clorox co-packaging agreement for Fresh Step coarse litter and a Walmart relationship at 19% of total sales. Ultra Pet added crystal-litter optionality and European distribution; the integration is behind them and accretive.

What has been de-risked: the commodity cost-pass-through mechanism (pricing actions held through three quarters of FY2026), the Ultra Pet integration, the balance sheet (debt-to-equity at 0.15, cash of $46.9M as of Q2 FY2026), and the capital-return posture (dividends, buybacks, 2-for-1 split, Series B/C/D senior-notes structure kept within investment-grade covenants).

What still looks stretched: the Walmart concentration (one retailer, 19–20% of consolidated sales); the Amlan animal-health segment (sold as a growth pillar, now declining); climate exposure at mining sites in Mississippi/Georgia/California after a Q2 FY2026 storm that cost meaningful revenue; and the valuation itself, which after a 228% run since 2022 now prices in mid-single-digit revenue growth indefinitely.

What to believe: that Oil-Dri can grow B2B fluids-purification revenue at high-single to low-double digits while protecting 25–30% gross margins, and that the Jaffee family will keep returning cash without doing anything reckless. They have now operated in public markets for sixty-plus years without a restatement, a covenant breach, or a control event.

What to discount: Amlan as a growth narrative until there is evidence the lost distributor customer has been replaced, and any implied extrapolation of the FY2024–FY2025 earnings curve into FY2026–FY2027 without accounting for the weather and cost normalization already visible in Q1–Q2 FY2026 comps.

The quiet compounder arrived in public view around the time of the Ultra Pet deal. The quiet part is over. What comes next will be judged against a very different bar.

Claude View

What's Next

ODC trades at $73.47 — within 1% of its 52-week high and up roughly 70% in twelve months — heading into a Q3 FY2026 print (mid-June) that will decide whether the gross-margin slip in Q2 (29.5% to 27.4%) was Winter Storm Fern noise or the start of a derate. Sell-side coverage is thin, the listed options chain is empty, and float is concentrated in a handful of active holders (GAMCO, BlackRock, Dimensional, Vanguard, Needham) plus the Jaffee family's ~70% voting block — so price discovery around the print will be purely spot-driven and potentially jagged.

The single most important data point in the next 90 days is Q3 FY2026 gross margin. Quant was explicit: the rerating from ~8x to 14.5x EV/EBITDA tracked the margin ladder one-for-one — a flat-to-up print validates the multiple, two consecutive quarters under 28% triggers the derate. The secondary watch is whether the Amlan customer that vanished in Q2 (animal-health revenue down 32% YoY) shows any sign of being replaced. Historian noted Amlan is the only growth pillar where management has had to publicly reset the story. Beyond earnings, the calendar-2026 proxy is the next governance pressure point: succession, the CEO's pledged 260,000 Class B shares, and the Vedder Price related-party fees all sit in plain view of any new institutional buyer doing diligence.

For / Against / My View

For

Against

My View

I'd lean cautious here rather than chase. The For side has the better long-form story — the B2B mix shift is real, ROIC is genuine, management has earned its credibility — but every one of those items is already in the 14.5x EV/EBITDA multiple and within 1% of the all-time high, while two Against items are live and dated: the Q2 gross-margin slip below Quant's 28% line and the Amlan customer loss that has not been recovered. The item that tips the scale for me is the asymmetry around the June Q3 print: if margin recovers, the stock probably grinds higher slowly from here; if it does not, the multiple compression Quant maps is significant and Sherlock's governance taxes start mattering more in the diligence call. I would wait for Q3 gross margin and an Amlan revenue update before paying this multiple. The view flips bullish if Q3 prints gross margin back at 29%+ with Amlan sequentially stable — at that point the rerating is validated on a clean comp and the Against side mostly evaporates.

Claude View

What the Internet Knows

An honest read of the web — proxy filings, Form 4s, earnings call transcripts on Motley Fool, trade press, Bloomberg, Reuters, EIA data, the company's own press releases — reveals a fundamentally different Oil-Dri than the one the 10-K describes. Three things change the investment picture versus the filings: (1) the Amlan animal-health growth story the company spent four years selling investors blew up in Q2 FY26 with a 32% YoY revenue collapse after a single distributor lost a single end-customer; (2) the renewable-diesel tailwind that pulled B2B operating margin to 33% is now cooling as the blender's tax credit converts to the 45Z producer credit and feedstock economics compress; and (3) the "family business" governance model at ODC is not a marketing story but a hard-wired dual-class structure in which Jaffee Investment Partnership controls 70%+ of Class B voting power — and minority shareholders have zero ability to challenge CEO Dan Jaffee's ~$10.6M annual compensation package. The stock nonetheless hit a 52-week high of $74.28 on April 17, 2026 — the day before this research was compiled — driven by a small-cap rotation and Forbes' recognition of ODC as a Most Successful Small-Cap Company for the third consecutive year.

What Matters Most

The findings below are ordered strictly by how much they should move an investor's view of ODC today, not by topic or source. Read top to bottom.

1. Amlan animal health collapsed 32% YoY in Q2 FY26 on the loss of a single distributor's key customer

Amlan revenue fell to $5.3M in the quarter ended January 31, 2026, down from $7.8M a year earlier — "driven by decreased volumes following the loss of a distributor's key customer." The company says it is "pursuing the recovery of this end-user and executing initiatives to expand distribution through both new and existing customers," but on the March 12 earnings call Amlan president Wade Robey characterized the loss as having "impacted our performance to date quite a bit" and did not provide a recovery timeline. For a segment that management had positioned as a multi-year double-digit grower with operating margins expanding into the high-20s, a single-customer concentration risk this large is material. (Oil-Dri Q2 FY26 press release; Motley Fool Q2 transcript)

2. Renewable-diesel filtration demand softened in the same quarter — fluids purification down 4% YoY to $25.5M

Fluids purification — the segment the bull case is built on and which drove 19% growth in FY24 — declined 4% in Q2 FY26. On the call, VP of Fluids Purification Bruce Patsey attributed the softness to the January 2025 expiration of the biodiesel blender's tax credit and its replacement with the 45Z producer credit, which temporarily reduced customer production volumes. He said higher fuel costs from "global conflict may temporarily spur fluid purification orders" but cautioned the benefit only materializes "if it stays a 30- to 60-day issue." The EIA's December 2025 Short-Term Energy Outlook cut its 2026 renewable-diesel production forecast, and farmdocDaily's November 2025 update shows US RD capacity consolidation (Chevron REG idling) now largely offsetting new Diamond Green expansions, with only 22 plants expected to be operational by year-end 2026. Metal-X and Metal-Z — ODC's proprietary trace-metal adsorbents for RD feedstock pretreatment — compete against BASF Sorbead, Clariant, W.R. Grace, and Honeywell UOP in what trade publications describe as a "moderated fragmented" adsorbent market. (Biodiesel Magazine; farmdocDaily; EIA biofuel imports analysis)

3. The Jaffee family's dual-class voting lock is absolute — and extends through a pledge of 260,000 Class B shares

Jaffee Investment Partnership, L.P. holds approximately 1,000,000+ Class B shares (70%+ of Class B outstanding, ~55% of aggregate voting power). Class B carries ten votes per share to Common's one; all director nominations, executive comp decisions, and M&A outcomes reflect this structure. Daniel S. Jaffee individually is the largest single shareholder at 7.5% of shares outstanding, followed by Gabelli Funds (9.3% of Common), Vanguard (7.3%), BlackRock (6.4%), and Needham Aggressive Growth (6.2%) — but none of these institutional holders have any practical voting influence because they hold Common, not Class B. The company has disclosed a pledge of 260,000 Class B shares by the Jaffee family; external reporting did not surface the margin-call trigger price, but at the current $73+ share price the pledge is comfortably in the money. (Oil-Dri institutional ownership page; Simply Wall St ownership analysis)

4. Dan Jaffee's total compensation is $10.6M, or 91.8% non-salary — with ISS giving the compensation pillar a 7 and the overall QualityScore an 8

Simply Wall St pulls ODC CEO compensation at $10.60M annually, of which only 8.2% is salary and 91.8% is bonuses, stock, and options. ISS's Governance QualityScore as of December 1, 2025 is 8 on a 1–10 scale where 10 is highest risk — with Board scoring 8, Shareholder Rights scoring 10 (worst possible), and Compensation scoring 7. There has been no shareholder say-on-pay dissent reported, because with Class B voting control the outcome is never in doubt. (Simply Wall St management; Yahoo Finance ODC profile)

5. Insider selling stepped up in mid-March 2026 — Director Paul Hindsley sold 6,000 shares; Director Ellen-Blair Chube sold 2,500 in June 2025

On March 13, 2026, Director Paul Hindsley (Senior Director, Investment Banking at William Blair & Company) sold 6,000 shares, and the stock "gapped down" on the Monday following, opening at $63.32 from a prior close of $65.43. Director Ellen-Blair Chube (former William Blair managing director) sold 2,500 shares on June 20, 2025. No insider buying activity has been reported in the last twelve months. The last insider trade prior to this cluster was April 21, 2025, per TipRanks. Two William Blair–affiliated directors selling within nine months, with no offsetting buys from the Jaffees, is the closest thing to a signal a dual-class-locked board can produce. (Daily Political Hindsley; Investing.com Chube)

6. Clorox Fresh Step co-pack agreement is exclusive for coarse clay >25% — and is the single biggest Retail concentration risk

The 2001 Memorandum of Agreement #1450 between A&M Products Manufacturing (Clorox subsidiary) and Oil-Dri grants ODC the "exclusive right to supply Clorox's requirements for Fresh Step coarse cat litter up to certain levels" — specifically any Fresh Step traditional coarse clay cat litter or combination product containing more than 25% coarse clay. Clorox retains the right to solicit bids for any Fresh Step variant containing less than 25% coarse clay (the lightweight and crystal formats where Clorox competes directly with ODC's own Cat's Pride brand). The agreement contains a 120-day discontinuance clause and redacted term and pricing details. Clorox's September 2023 cyberattack disrupted Fresh Step production and cost ODC measurable co-pack revenue; Bloomberg reported in September 2024 that Clorox is still "struggling to win back cat litter shoppers" from the outage. (SEC filing of MOA #1450; Bloomberg)

7. The US cat-litter category is shifting to crystals — and ODC paid $46M to buy in through Ultra Pet

Ultra Pet Company was acquired May 1, 2024 for $46M in cash (roughly 1.9x sales, given Ultra Pet's ~$24M annual revenue at close). ODC's press release cited NielsenIQ and Stackline data showing the crystal cat litter segment grew 500% between 2019 and 2024 — driven by e-commerce, premium pet humanization, and crystals' 99.9% dust-free, lightweight, high-absorption profile. In Q3 FY25 Ultra Pet contributed $4.8M to R&W segment revenue. Management launched Cat's Pride Micro Crystal Litter in March 2025 leveraging Ultra Pet's silica-gel formulation, and Q2 FY26 results note "increased demand for crystal cat litter products" as a positive driver even as overall clay litter was "slightly tempered by heightened promotional activity from competitors." The broader cat litter market is projected to grow from $14.67B in 2025 to $19.25B in 2032 (CAGR 3.95% per Fortune Business Insights). (Oil-Dri Ultra Pet close press release; Fortune Business Insights)

8. Share repurchase pace stepped up roughly 7x in fiscal H1 2026

On the March 11, 2026 release, management stated that year-to-date share repurchases had exceeded 150,000 shares, and the Q2 earnings call confirmed total H1 FY26 buybacks of roughly $19.4M — versus a historical pace of roughly $3M per half. Cash at January 31, 2026 was $46.9M against $40M in debt, leaving ODC in a net-cash position with continued capacity. Management did not provide a remaining authorization size on the call, but the tone ("Our confidence in our business remains strong and is reflected in the repurchase of over 150,000 shares year-to-date") signals continued willingness to buy at $70+. (Q2 press release)

9. Winter Storm Fern disrupted Q2 FY26 operations — meaningful revenue slippage into Q3

Winter Storm Fern in January 2026 temporarily shut down several southern and eastern US plants, delayed logistics, and produced a $2.8M backlog increase in R&W at quarter-end. Management described "meaningful shift of revenues into the next reporting period" and confirmed full operational recovery by the reporting date. Gross margin compressed to 27.4% from 29.5% YoY on poor fixed-cost absorption. This is transitory — Q3 FY26 should see a margin reversal and a revenue catch-up — but it is the biggest single reason management's Q2 print fell short of consensus expectations. (Q2 press release)

10. The stock hit an all-time high of $74.28 on April 17, 2026 — one day before this report

ODC's common closed April 17 at $73.47, +3.64% on the day, with the intraday high of $74.28 setting a new all-time record. The 52-week range is $41.37 – $74.28. Market cap is $1.064B, P/E (TTM) 21.4, EBITDA (TTM) $84.9M, ROE 19.8%, net margin 11.0%. Forbes published its 2026 list of America's Most Successful Small-Cap Companies with ODC named for the third consecutive year on December 3, 2025. Simply Wall St's model places intrinsic value at $117/share under a Peter Lynch formula and Alpha Spread's base case at $50.99; the Street consensus target is unavailable because sell-side coverage is thin (no Goldman, Morgan Stanley, or JP Morgan coverage surfaced in any search). (CNBC quote; Value Investing IO; Alpha Spread)

Recent News Timeline

What the Specialists Asked

Insider Spotlight

Key takeaways. Dan Jaffee has been CEO for 31 years — the longest tenure on the ODC roster by a factor of three. His compensation is not tied meaningfully to performance in the "salary vs bonus" sense (only 8.2% salary), but the stock-linked portion means his interests are structurally aligned with share-price appreciation. What the alignment does not solve: with Class B control the Jaffee family could in principle take actions that hurt Common holders without consequence at the ballot box.

The only insider selling in the last 12 months has come from two William Blair–affiliated independent directors. No family or senior management insider has bought shares in the open market in at least a year. In a dual-class structure this matters less than at a one-share-one-vote company, but it is not a positive tell.

The Vedder Price legal-fee relationship with Director Nemeroff ($1.59M FY25) is a classic related-party setup that would typically trigger an ISS "against" recommendation at a non-controlled company. With Class B voting control, the outcome is moot.

Industry Context

Cat litter category. Global cat-litter market projected at $14.67B (2025) growing to $19.25B (2032) at 3.95% CAGR (Fortune Business Insights). Mordor Intelligence places the same market at $6.26B in 2026 growing at 4.14% CAGR to $7.66B in 2031 (narrower methodology — US retail only, excluding Asia). The structural shift is clay-to-crystal — the crystal segment grew 500% between 2019 and 2024 per NielsenIQ/Stackline data ODC cited in the Ultra Pet acquisition release. Lightweight clumping continues to outgrow the overall category (Q2 FY26 NielsenIQ data). E-commerce is the fastest-growth channel at 6.3% CAGR (Grand View Research). Top brands by dollar share: Tidy Cats (Purina/Nestlé), Fresh Step (Clorox), Arm & Hammer (Church & Dwight), then Cat's Pride (ODC) and a long tail of private label. Clorox's 2023 cyberattack created a one-time share gap that Fresh Step has partially but not fully recovered (Bloomberg, September 2024).

Renewable diesel. EIA forecasts 255,000 b/d US RD production in 2026 — an all-time annual high. The blender's-to-45Z producer credit shift in January 2025 caused US biofuel imports to drop to a decade low and temporarily compressed RD producer margins. EPA's 2026 RVO of 5.61B gallons and biomass-based diesel mandate of 7.12B RINs are supportive. 22 US RD plants expected operational year-end 2026 (farmdocDaily). Key refiners: Diamond Green (Valero/Darling), Marathon Martinez, Phillips 66 Rodeo, Chevron REG. Chevron REG has idled capacity that offsets Diamond Green expansions, so aggregate capacity growth is slowing in 2026–27.

Bleaching clay / fluids purification market. Competitors include BASF (Sorbead), Clariant, W.R. Grace, Honeywell UOP, Arkema, Cabot, Axens, and Calgon Carbon. This is a "moderated fragmented" market (Databridge Market Research) where regional presence and technical-service capability matter as much as formulation. Oil-Dri's Metal-X and Metal-Z are positioned specifically for RD feedstock trace-metal removal — a niche within the broader adsorbents market.

Animal health feed additives. Amlan competes in a very large but fragmented market against companies like Alltech, Kemin, DSM-Firmenich, and dozens of specialty players selling mycotoxin binders, gut-health additives, and calcium-montmorillonite products. Amlan's thesis is "mineral science by Oil-Dri" — proprietary thermally-processed calcium montmorillonite (Calibrin-Z, Varium) for poultry, swine, dairy, and aquaculture. The Q2 FY26 revenue collapse exposes how concentrated Amlan's customer book actually is.